The Authors' Reply
Year of publication: |
2010
|
---|---|
Authors: | Kapoor, Alok ; Radhakrishnan, Nila ; Smith, Kenneth J. |
Published in: |
PharmacoEconomics. - Springer Healthcare | Adis, ISSN 1170-7690. - Vol. 28.2010, 9, p. 782-784
|
Publisher: |
Springer Healthcare | Adis |
Subject: | Anticoagulants | therapeutic use | Antithrombotics | Ardeparin-sodium | Cost-effectiveness | Dabigatran-etexilate | Dalteparin-sodium | Deep-vein-thrombosis | prevention | Enoxaparin-sodium | Factor-Xa-inhibitors | Low-molecular-weight-heparins | Pulmonary-embolism | Research-and-development | Rivaroxaban | Tinzaparin-sodium | Warfarin |
Extent: | application/pdf text/html |
---|---|
Type of publication: | Article |
Classification: | C - Mathematical and Quantitative Methods ; D - Microeconomics ; I - Health, Education, and Welfare ; Z - Other Special Topics ; I1 - Health ; I19 - Health. Other ; I18 - Government Policy; Regulation; Public Health ; I11 - Analysis of Health Care Markets |
Source: |
-
McCullagh, Laura, (2010)
-
Kapoor, Alok, (2010)
-
Plumb, Jonathan M., (2010)
- More ...
-
Kapoor, Alok, (2010)
-
Kapoor, Alok, (2010)
-
Academic Dishonesty—Cheating Behaviour and Other Forms of Inappropriate Conduct
Smith, Kenneth J., (2012)
- More ...